SPP1 and lung carcinoma: In non-small-cell lung cancer, higher serum levels of osteopontin, a glycophosphoprotein that has been implicated in tissue remodeling, were noted in patients with osteopontin-positive versus -negative lung cancers, as evaluated by IHC [23].